<DOC>
	<DOCNO>NCT00970073</DOCNO>
	<brief_summary>This study evaluate use drug call Thymoglobulin , combine delayed start anti-rejection drug ( 10 day liver transplant ) , compare current approach start anti-rejection drug call calcineurin inhibitor CNI 's within 2 day liver transplant .</brief_summary>
	<brief_title>Low Dose Thymoglobulin Protect Kidney Function After Liver Transplant</brief_title>
	<detailed_description>Strong anti-rejection drug like tacrolimus cyclosporine , give patient receive transplant , ensure patient 's body reject new organ . In case , anti-rejection medication protect newly transplant liver , injure patient 's kidney cause work well . The purpose pilot study determine best way protect kidney function ensure newly transplant liver reject . This study evaluate use drug call Thymoglobulin , combine delayed start anti-rejection drug ( 10 day liver transplant ) , compare current approach start anti-rejection drug call calcineurin inhibitor CNI 's within 2 day liver transplant .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Patients undergo deceased donor solitary liver transplantation Adults age 1870 time transplantation Hepatocellular carcinoma indication OLT within Milan Criteria Hepatitis C positive negative patient Willingness comply study procedure Able sign inform consent Prior kidney transplantation Congenital iatrogenic absence one kidney Subjects renal replacement therapy time OLT MELD score &gt; 28 HIV positive patient Patient current severe systemic infection History bacterial peritonitis within 30 day prior OLT Active infection recent infection within 30 day prior OLT Use calcineurin inhibitor continuously 90 day within past 6 month History hypersensitivity thymoglobulin , rabbit , tacrolimus iohexol Women childbearing age unwilling use effective contraceptive method duration study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>calcineurin inhibitor delay</keyword>
	<keyword>Kidney</keyword>
</DOC>